Mediantechn (ALMDT)

Currency in EUR
4.650
+0.065(+1.42%)
Closed·
ALMDT is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
4.5204.740
52 wk Range
1.4287.270
Key Statistics
Prev. Close
4.585
Open
4.58
Day's Range
4.52-4.74
52 wk Range
1.428-7.27
Volume
158.68K
Average Volume (3m)
330.62K
1-Year Change
187.037%
Book Value / Share
-0.96
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ALMDT Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
11.967
Upside
+157.35%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts do not anticipate the company will be profitable this year

Mediantechn News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Buy
Moving Averages
Sell

Analyst Ratings

3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 11.967
(+157.35% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Apr 23, 2026
EPS / Forecast
-- / --
Revenue / Forecast
5.8M / --
EPS Revisions
Last 90 days

ALMDT Income Statement

Compare ALMDT to Peers and Sector

Metrics to compare
ALMDT
Peers
Sector
Relationship
P/E Ratio
−5.1x−0.8x−0.4x
PEG Ratio
−0.160.030.00
Price/Book
−5.0x2.0x2.6x
Price / LTM Sales
7.4x2.2x3.0x
Upside (Analyst Target)
159.5%62.8%57.0%
Fair Value Upside
Unlock25.0%9.1%Unlock

Median Technologies SA engages in providing medical imaging products and services for diagnosing and monitoring cancer patients in both routine clinical practice and clinical drug development with operations spanning in France, the United States, Canada, the United Kingdom, China, and internationally. The company offers iSee for imaging services in clinical trials; eyonis for non-invasive diagnostic tests based on imaging for the diagnosis and treatment of patients suffering from cancer; and iCRO, a central imaging service and AI-powered Imaging Lab. Also, the company focuses on the oncology clinical trials market and the cancer patient care market. The company was founded in 2002 and is based in Valbonne, France.

Employees
199
Market
France

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
2.90M7.59%13.29M
Other Institutional Investors
12.62M33.07%57.87M
Public Companies & Retail Investors
22.65M59.34%103.83M
Total
38.16M100.00%174.98M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Celestial Successor Fund L.P.6.69%2,553,31211,707
Lake Bridge Capital Inc6.69%2,553,31211,707

People Also Watch

30.96
AL2SI
+12.50%
8.00
ALKAL
-0.25%
83.30
ABVX
-1.42%
0.2280
ALHAF
+5.07%
31.12
NANOB
+0.13%

FAQ

What Is the Mediantechn (ALMDT) Stock Price Today?

The Mediantechn stock price today is 4.650 EUR.

What Stock Exchange Does Mediantechn Trade On?

Mediantechn is listed and trades on the Paris Stock Exchange.

What Is the Stock Symbol for Mediantechn?

The stock symbol for Mediantechn is "ALMDT."

What Is the Mediantechn Market Cap?

As of today, Mediantechn market cap is 180.900M EUR.

What Is Mediantechn's Earnings Per Share (TTM)?

The Mediantechn EPS (TTM) is -0.928.

When Is the Next Mediantechn Earnings Date?

Mediantechn will release its next earnings report on Apr 23, 2026.

From a Technical Analysis Perspective, Is ALMDT a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Mediantechn Stock Split?

Mediantechn has split 0 times.

How Many Employees Does Mediantechn Have?

Mediantechn has 199 employees.

What is the current trading status of Mediantechn (ALMDT)?

As of Jun 29, 2026, Mediantechn (ALMDT) is trading at a price of 4.650 EUR, with a previous close of 4.585 EUR. The stock has fluctuated within a day range of 4.520 EUR to 4.740 EUR, while its 52-week range spans from 1.428 EUR to 7.270 EUR.

What Is Mediantechn (ALMDT) Price Target According to Analysts?

The average 12-month price target for Mediantechn is 11.967 EUR, with a high estimate of 14 EUR and a low estimate of 10 EUR. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +157.35% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.